000			01742 a2200457 4500
005			20250514155403.0
264		0	_c20031030
008			200310s 0 0 eng d
022			_a1464-4096
024	7		_a10.1046/j.1464-410x.2003.04425.x _2doi
040			_aNLM _beng _cNLM
100	1		_aHopps, C V
245	0	0	_aNovel agents for sexual dysfunction. _h[electronic resource]
260			_bBJU international _cOct 2003
300			_a534-8 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdministration, Topical
650	0	4	_aAdrenergic alpha-Antagonists _xtherapeutic use
650	0	4	_aAlprostadil _xadministration & dosage
650	0	4	_aAmides _xtherapeutic use
650	0	4	_aCalcium Channels _xphysiology
650	0	4	_aDopamine Agonists _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEndothelial Growth Factors _xtherapeutic use
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aErectile Dysfunction _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntercellular Signaling Peptides and Proteins _xtherapeutic use
650	0	4	_aLymphokines _xtherapeutic use
650	0	4	_aMale
650	0	4	_aNitric Oxide Synthase _xtherapeutic use
650	0	4	_aPhosphodiesterase Inhibitors _xtherapeutic use
650	0	4	_aPyridines _xtherapeutic use
650	0	4	_aReceptors, Corticotropin _xantagonists & inhibitors
650	0	4	_aReceptors, Melanocortin
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aMulhall, J P
773	0		_tBJU international _gvol. 92 _gno. 6 _gp. 534-8
856	4	0	_uhttps://doi.org/10.1046/j.1464-410x.2003.04425.x _zAvailable from publisher's website
999			_c14271857 _d14271857